SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sun Pharma & Pharmazz Inc. enter into licensing agreement for introducing Tyvalzi (Sovateltide) in India14-09-2023
14-09-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss intimation attached11-09-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation -Sept 202311-09-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 29, 2023 for Raksha Sudhir Valia30-08-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Submission Of ESG Overview For Financial Year 2022-23
We are submitting the ESG Overview of the Company for the financial year 2022-23, which shall be released after this submission.29-08-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results and Scrutinizer''s Consolidated Report of the 31st Annual General Meeting of the Company held on August 28, 2023 are attached.29-08-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 31st AGM of the Company is attached.28-08-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Speech Delivered At 31St Annual General Meeting
Please find enclosed herewith the speech delivered at the 31st Annual General Meeting held on August 28, 2023.28-08-2023
Taro stake buyout to help operate its dermatology biz profitably amid enhanced competition: Sun Pharma
The Mumbai-based drug major has proposed to fully acquire Taro through a reverse triangular merger27-08-2023